EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice

Sara A Healy, Charles Anderson, Bruce J Swihart, Agnes Mwakingwe, Erin E Gabriel, Hope Decederfelt, Charlotte V Hobbs, Kelly M Rausch, Daming Zhu, Olga Muratova, Raul Herrera, Puthupparampil V Scaria und 8 weitere

Journal of Clinical Investigation · 01.04.2021 · 131 (7)

DOI: 10.1172/jci146221 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Investigation, online erschienen am 01.04.2021. Verfasst von Sara A Healy und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Malaria Immunology and Vaccinology, and. Die Arbeit wurde bisher 107-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAluminum HydroxideAnimalsAntibodies, ProtozoanAntigens, ProtozoanFemaleHumansMacaca mulattaMalaria VaccinesMalaria, FalciparumMaleMiceMice, Inbred BALB CPlasmodium falciparumProtozoan Proteins

Stichwörter der Autor:innen

Infectious diseaseMalariaVaccines

Substanzen

Antibodies, ProtozoanAntigens, ProtozoanMalaria VaccinesPfs230 antigen, Plasmodium falciparumPfs25 protein, Plasmodium falciparumProtozoan ProteinsAluminum Hydroxide

Autor:innen und Institutionen

  • Laboratory of Malaria Immunology and Vaccinology, and.
  • Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Pharmacy Department, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

Förderung

  • Intramural NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Healy, S. A., Anderson, C., Swihart, B. J., Mwakingwe, A., Gabriel, E. E., Decederfelt, H., Hobbs, C. V., Rausch, K. M., Zhu, D., Muratova, O., Herrera, R., Scaria, P. V., MacDonald, N. J., Lambert, L. E., Zaidi, I., Coelho, C. H., Renn, J. P., Wu, Y., Narum, D. L., & Duffy, P. E. (2021). Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice. Journal of Clinical Investigation, 131(7). https://doi.org/10.1172/jci146221

Vancouver

Healy SA, Anderson C, Swihart BJ, Mwakingwe A, Gabriel EE, Decederfelt H, et al. Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice. Journal of Clinical Investigation. 2021;131(7). doi:10.1172/jci146221

BibTeX
@article{Healy2021,
  author = {Healy, Sara A and Anderson, Charles and Swihart, Bruce J and Mwakingwe, Agnes and Gabriel, Erin E and Decederfelt, Hope and Hobbs, Charlotte V and Rausch, Kelly M and Zhu, Daming and Muratova, Olga and Herrera, Raul and Scaria, Puthupparampil V and MacDonald, Nicholas J and Lambert, Lynn E and Zaidi, Irfan and Coelho, Camila H and Renn, Jonathan P and Wu, Yimin and Narum, David L and Duffy, Patrick E},
  title = {Pfs230 yields higher malaria transmission–blocking vaccine activity than Pfs25 in humans but not mice},
  journal = {Journal of Clinical Investigation},
  year = {2021},
  volume = {131},
  number = {7},
  doi = {10.1172/jci146221}
}
Kostenlos starten →